|
|
StimateMs. Pia NSBORG ANDERSEN Danish Medicines Agency Frederikssundsvej 378 DK-2700 Brnshj. MP did not affect the transport of [ 11C]raclopride from blood to brain K1 ; in striatum or in cerebellum nor did it affect the distribution volume DV ; in cerebellum Table 1 ; . In contrast, MP significantly reduced the DV in striatum F 18; df 1, 10; p 0.002 ; Table 1 ; . This can be seen in Figure 1, which shows representative DV images for [ 11C]raclopride images at the level of striatum and at the level of the cerebellum obtained after placebo and after MP. MP significantly reduced the estimates for 12%; DA D2 receptor availability Bmax Kd ; in striatum 20 F 26; df 1, 10; p 0.0004 ; Fig. 2 A ; . MP-induced changes in Bmax Kd showed a large intersubject variability range, 3 48% ; . The magnitude of the changes in Bmax Kd were found to be inversely correlated with age r 0.73; df 10; p 0.01 the larger changes were observed in the youngest subjects Fig. 2 B. The epidemic of human immunodeficiency virus type 1 HIV-1 ; in Argentina is distinctive in that many infections are caused by subtype BF recombinant viruses. To determine their demographic history, we estimated the evolutionary rate, mode of population growth, and age of genetic diversity among 40 BF vpu sequences. This revealed one of the highest substitution rates reported for HIV-1, at 10.793 10 3 substitutions per site per year, and a very rapid rate of population growth, with an initial mean epidemic doubling time of 3.72 months. This rapid population growth is compatible with an elevated fitness for subtype BF compared to that for "pure" B and F viruses. Pharmaceutical companies spend large sums of money on the promotion of their products. In an absolute sense this is not surprising, since the pharmaceutical sector is very large: in 1996, 1.2% of GDP in industrialised countries was spent on pharmaceuticals. But pharmaceutical promotion outlays are large in a relative sense as well. In the entire economy, firms spend an average of 2% of their revenues on promotion. For pharmaceutical firms this percentage is much higher; estimates imply that around 15%-25% of their revenues are spent on promotion. In many countries insurance or tax systems are in place such that the consumer of pharmaceutical products does not bear the full direct costs of pharmaceutical consumption. In the country under study in this paper, the Netherlands, the drugs prescribing decision is made by a general practitioner GP ; or specialist. The financial incentives for doctors to prescribe cheap drugs if they are available as an alternative are very weak. Together with a general insurance system, the price elasticity of demand for drugs is therefore expected to be small. As physicians are the main decision-makers, most of pharmaceutical companies' promotion activities are directed to general practitioners and specialists. As large promotion outlays in a market with inelastic demand will lead to higher prices, it is important to assess the welfare aspects of pharmaceutical companies' marketing activities. Promotion can have two effects on demand: it may shift the demand curve outwards as doctors prescribe more of the advertised drug and it may rotate the demand curve as demand becomes less or more price-elastic than before. In general, if product promotion lowers the price sensitivity, this will inhibit price competition and will lead to higher prices, thus harming social welfare. An outward shift of the demand curve for a drug could be socially desirable if this drug truly improves health at a reasonable cost. However, if promotion is merely a means of establishing market share, even when cheaper, therapeutically equivalent drugs are available, the promotion efforts may be socially harmful. Using a unique data set that contains monthly information on demand, prices and promotion outlays for a large number of prescription drugs in the Netherlands during the years 1994-1999, a model is estimated to test whether promotion expenditures have an effect on the demand of pharmaceuticals. Indeed, we find that promotion expenditures rotate the demand curve and adversely affect the own-price elasticity of drugs, reducing a potentially small negative price elasticity to almost zero. Thus the promotional expenditures make doctors less sensitive to prices when deciding which pharmaceutical should be described. Identification of the promotion effect on the price elasticity of demand is due to the introduction of the Pharmaceutical Prices Act, which established that Dutch drugs prices became a weighted average of the prices in the surrounding countries. This act came into effect in June 1996 and established that prices and promotion expenditures could no longer be set simultaneously by the drug producers. Presented with three lures for a recognition trial; lures were chosen to have plausible links to the target word. The low threshold in counting a word as correct was chosen so as to minimize the influence of general intelligence on the test. For example, all answers that included either the word "radio" or "cassette" were counted as correct for the "walkman" item. Lures for this item were, in translation, "someone who lays roofs", "powerful walky-talky", and "son of gods in German mythology", which were presented along with the correct definition given as "portable cassette player with head phone" ; . The item pool of the NVT was constructed using dictionaries of neologisms. Items were first sifted by eliminating those that were not answered correctly by all participants in a small pilot group. Slightly more neologisms than ended up in the final test were presented to a stratified sample of 70 adults, whose age ranged from 33 to 88 stratification was done with respect to age, sex and level of education ; . Items answered correctly in their open format by more than 90% of participants were included in the test. This resulted in the present test, on which the normal controls in the sample scored 90% correct. There were no differences in the score on the different periods in the test, and no gender, age or education effects were found de Wilde, 2001 ; . Episodic memory tests To test episodic anterograde memory, the eight-word list-learning test was used Lindeboom & Jonker, 1989 ; . For this test, eight unrelated words are read to the subject five times. Immediately after each presentation recall is tested, with the total number of words recalled after the five trials being used as the score. In addition, recall was again tested after a delay of 10 minutes followed by a recognition test in which the eight words were intermixed with eight distracters Schmand, 1997 ; . As a test of episodic retrograde amnesia, the Dutch adaptation of the Autobiographical Memory Interview AMI, Kopelman et al., 1990; Kopelman et al., 1989; Meeter & Murre, 2003 ; was partially administered. This test consists of `personal semantic' questions precise questions about factual information ; , and 9 `incident' questions, in which respondents must generate an anecdote from different periods in their life of the respondent. Only these last questions were put to the participants in this study because of time considerations. These nine questions, though referring to precisely dated events, are grouped into three broader periods: childhood 0-18 years ; , young adulthood 18-32 ; and recent time periods last 5 years ; . Scoring of each generated incident is on a three-point scale, and based on the descriptive richness of the account of an incident and its specificity in time and place. Premorbid intelligence, executive function and language The Dutch version of the National Adult Reading Test NART, Nelson & O' Connell, 1978 ; was used as an estimator of premorbid intelligence. The NART consists of a list of words with irregular spelling that must be read aloud. The number of correctly pronounced words can be used to estimate IQ. This estimate is relatively stable, even after cerebral damage Bright et al., 2002 ; . However, recent evidence suggests that it declines in dementia, and that it may thus underestimate premorbid IQ in patients with more severe dementia Cockburn et al., 2000; Schmand et al., 1998 ; . Formulas have been proposed for correcting NART-based IQ estimates with help of MMSE scores, but here we will report raw NART scores. The meander appeals to cognitive flexibility and self-monitoring Lindeboom & Jonker, 1989; Luria, 1966 ; . The meander consists of an alternating line pattern printed on a sheet of paper, and the subject is asked to continue this line pattern on the sheet with a pencil. Impairment is seen in perseverations difficulty in switching ; and in stereotypical behavior. This task may be sensitive to prefrontal dysfunction Lezak, 1995 ; . For the present study, we used a simplified scoring system in which lines generated by participants were classified as either correct or incorrect. Correct answers consist of an alternating pattern without errors. To assess language disorders, we included two subtests of a screening instrument for aphasia. ' Sentence construction' a test in which participants have to construct a sentence to describe each of is ten pictured events Deelman et al., 1981 ; . Sentences are scored as incorrect if they contain errors in syntax or semantics. In a second task, object naming, participants had to provide the names of 18. Completion Time: The estimated time to complete this activity is 1 hour. Target Audience: Physicians and podiatrists Learning Objectives: Upon completion of this educational activity, participants should be able to: Discuss the pathophysiology of venous disease Discuss how treatment options for venous disease have changed Describe advances in technology and treatment of venous diseases Define abnormalities in wound healing Discuss how and why cell therapy works in treatment List the indications for use of cell therapy in the treatment of ulcers. Method of Participation: Participants must read the article then take, submit, and pass the post-test by April 15, 2008. Participants must completely fill out the answer evaluation form, answer at least 70% of the questions correctly, and mail or fax the answer evaluation form to: NACCME, 83 General Warren Blvd., Suite 100, Malvern, PA 19355; fax: 610-560-0501. Accreditation: MD DO: This activity is sponsored by the North American Center for Continuing Medical Education NACCME ; . NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The North American Center for Continuing Medical Education designates this continuing medical education activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity and desmopressin. Because the provisions on nulev the estimates occurring. Department. We collected blood samples for malaria parasites from all children who had fever or a history of fever during the previous two days. We used an inpatient morbidity questionnaire to assess children who were admitted to the hospital and took blood samples for microscopy and determination of packed cell volume. Study children were visited at home at 18 months of age to collect finger prick blood samples for assessing packed cell volume and the presence of malaria parasitaemia and again at 23 months of age to assess their health. The study physician certified the cause of death of children who died in the hospital. We assessed cause of death of children who died at home by verbal autopsy.12 A fieldworker visited a random 20% sample of study children at home within four weeks after administration of IPT dose 1 or dose 2 to assess adherence to administration of iron at home and to inquire about adverse events. Children who had any rash other than scabies, heat rash, or insect bites were referred to the project physician for a clinical assessment. Ethical clearance and analytical plan An independent statistician Simon Cousens ; and epidemiologist Laura Rodrigues ; approved the analytical plan. We cleaned and audited the data before locking the data and unmasking the intervention codes. The primary outcomes, defined in the analytical plan, were the incidence of all episodes of malaria associated fevers history of fever or temperature 37.5C plus malaria parasites detected on a blood smear ; detected in study children attending the health centres or the hospital and the incidence of anaemia packed cell volume 24% ; in children admitted to the study hospital for any illness. We stratified analyses by age 2-15 months and 16-23 months ; to assess the effect of IPTi during the intermittent treatment phase 2-15 months ; and after the effect of the intervention had ceased 16-23 months ; . We decided a priori to investigate the effect of sex, urban residence, and mosquito net use on the outcome, including only those covariates that were significantly associated with the outcome P 0.1 ; in the final model. Because of the highly seasonal nature of transmission of malaria at the study site, we compared the effect of IPTi administered during the wet season JulyNovember ; with IPTi administered during the dry season December-June ; . We restricted this analysis to 2-12 month old infants. We estimated the protective efficacy of IPTi against malaria, anaemia, and hospital admissions by all combinations of timing of IPTi doses. Statistical methods We analysed data on an intention to treat basis, including all infants who were enrolled, at the time of receipt of DPT-1, regardless of whether they received any doses of IPT. Time at risk started at enrolment, approximately four weeks before the first dose was administered and will, therefore, give a conservative estimate of the effect of IPTi. Thirty episodes of malaria occurred in 127.5 person years at risk in the placebo group and 30 episodes in 127.1 person years at risk in the sulfadoxine-pyrimethamine group in the period between enrolment and the first dose received. We analysed data by using random effects Poisson or negative binomial regression models to allow for intraBMJ VOLUME 331 1 OCTOBER 2005 bmj and decadron. Question: Is it ethical to provide short-term therapy by telephone, e.g., through a toll-free line or a 900 number? Answer: The concern about this is if a referral for in-person treatment will be made if needed; it is unclear how such a determination can be made over the telephone. Without the direct contact in a face-to-face initial evaluation, it is difficult for a physician to provide competent medical or psychiatric evaluation and treatment. A psychiatrist who participates in such a service might be at risk of violating several principles of medical ethics that deal with the provision of competent medical service, and so forth. February 1994. Returning to our scenario, to estimate the magnitude of the fracture reduction we might expect with raloxifene where we only have surrogate end point data ; , we could recognizing the limitations of this approach pointed out above ; examine the results of randomized controlled trials of alendronate a drug from a different class in which we have data on the same surrogate end point as well as clinical end points such as fracture reduction and dexamethasone.
The ADVIA 1650 analyzer Bayer Diagnostics; Bershire, UK ; was used to estimate serum creatinine, calcium, albumin, urine creatinine, and urine calcium levels. The Jaffe reaction and enzymatic reaction of Tanganelli was used to measure urine creatinine and serum creatinine respectively. The Doumas, Watson, and Biggs method using bromcresol green as the binding dye was used to estimate serum albumin. The reaction between calcium and o-cresolphthalein complex one was used to measure serum and urine calcium. Serum intact parathyroid hormone iPTH ; was estimated using a solid-phase, two-site, chemiluminescent enzyme-labeled immunometric assay in the Immulite 2000 analyzer DPC; Scientific Supplies and Technology; Miami, FL ; . A double-antibody, sequential, 125I-labeled radioimmunoassay was used to estimate serum estradiol. An ADVIA Centaur immunoassay system Bayer ; was used to estimate serum prolactin, follicular-stimulating hormone FSH ; and leutinizing hormone LH ; levels. These assays were two-site "sandwich" immunoassays. Serum 25 hydroxyvitamin D was measured using DiaSorin 25 hydroxy vitamin D radioimmunoassay DiaSorin; Stillwater, MN ; . Rate spectrophotometric method using reagents from Sigma Diagnostics Columbia, MD ; was used in the measurement of serum angiotensin-converting enzyme ACE ; levels. Serum 1, 25 dihydroxyvitamin D was estimated by a competitive radioimmunoassay kit manufactured by DiaSorin. The vitamin D metabolites were extracted and purified using a C18 cartridge, followed by radioimmunoassay using a polyclonal antibody that is specific to both 1, 25 OH ; 2D2 and 1, 25 OH ; 2D3. Statistics The variables are expressed as mean SD. The Spearman correlation was used to assess correlation between the continuous variables and phenoxybenzamine. 2006 Equity Debt Estimated future benefit payments: The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid: Year ended March 31, 2007 2008 to 2017 Rs.23, 473 28, 118 Rs.150, 502 27% 73. Endometriosis is a chronic disease manifested by pelvic pain and infertility and defined as the presence of endometrial glands and stroma within the pelvic peritoneum and other extra-uterine sites. It is estimated to affect 210% of women in the reproductive age group Vessey et al. 1993, Kjerulff et al. 1996 ; . Endometriosis is viewed to be a polygenically inherited disease of complex multifactorial etiology Olive & Schwartz 1993 ; . Sampson's theory of transplantation of endometrial tissue on the pelvic peritoneum via retrograde menstruation is the most widely accepted explanation for the development of pelvic endometriosis because of convincing circumstantial and experimental evidence Sampson 1927 ; . Since retrograde menstruation is observed in almost all cycling women, endometriosis is postulated to develop as a result of the coexistence of a defect in clearance of the and phenytoin and stimate. Chronobiol Int 2000 ; 17: 233-43 Acknowledgments : This study was supported by INRETS : Institut National de Recherche sur les Transports et leur Scurit. Arcueil France. 385.H Self-Reported Sleep Patterns and Sleep-Related Characteristics of `Young-Old' and `Old-Old' Community Dwelling Seniors Smith CS, 1 Wilson NM, 1 Lichstein KL, 1 Durrence HH, 1 Taylor DJ, 1 Bush AJ, 2 Riedel BW1 1 ; The University of Memphis, Memphis, TN, 2 ; The University of Tennessee, Memphis, TN Introduction: The range of ages qualifying an individual as an older adult can span 30 + years. As a result, aging researchers often divide their samples into `young old' and `old old' 75 + ; groups. Although sleep researchers rarely utilize this distinction, evidence that sleep worsens with age suggests such distinction may help elucidate the nature of sleep in aging. The present study examines sleep and factors associated with age-related increases in sleep difficulties health, medication, psychological distress ; in young old and old old elderly. Methods: Random-digit dialing was used to recruit at least 50 males and 50 females in each decade 20- 80 + ; . Participants completed 14 sleep diaries and several sleep-related questionnaires. A subset of 322 older individuals from this normative sample were divided into young old 6074 years; n 175; 76 M & 79 F ; and old-old 75-98 years; n 147; 75 M & 72 F ; groups. Results: ANOVA see table ; and regression analyses were used to compare the young old and old old groups on eight sleep variables, two psychological measures, and two health items. Sleep variables included: SOL, NWAK, WASO, TST, SE, TIB, quality, and naps. Psychological measures included: State-Trait Anxiety Inventory, Trait-STAI and Beck Depression Inventory-BDI. Health-related items included: number of medical conditions and number of medications. Sleep Variables. Significant group differences were found for all sleep variables except sleep quality and WASO. Young old took less time to fall asleep, slept more efficiently, awoke less, and napped less than old old. Interestingly, both age groups rated their sleep quality as fair and had about 30 minutes of unwanted nightly awake time. Psychological Measures. Young old reported significantly less depression than old old; the two groups did not differ in anxiety. Health Items. Significant group differences were found for number of medical conditions but not for number of medications. On average, old old reported more medical conditions than did young old. Medication usage did not differ with both groups taking only 2-3 medications on average. Because SE provides a good overall estimate of an individual's sleep, a stepwise regression analysis was performed with SE as the dependent variable and the sleep-related measures and several demographic variables as independent variables. For young old, anxiety accounted for 10.7% of the variance in sleep efficiency followed by gender 4.1% ; and history of mental health problems 3.6% ; . For old old, number of medical conditions accounted for 15.0% of the variance in sleep efficiency followed by gender 4.1% ; and anxiety 3.0. Figure 1 pursuit xrs demonstrates improved resolution and superior peak shape on polar pharmaceuticals compared to competitor's columns and valsartan. Medications Cheap Drugs2.10 To create awareness amongst and assist Micro, Small and Medium Enterprises SMEs ; to respond to the opportunities and challenges emerging under the World Trade Organisation WTO ; regime. A WTO Cell shall be established in the Industries Department. 2.11 To maximize industry and institution linkages in the areas such as manpower planning, research and development etc. 2.12 To make concerted efforts for balanced regional development. 3. STRATEGY 3.1 To create an enabling environment for development of industrial and related social infrastructure of international standards. 3.2 Human Resources Development to create competitive scientific and technical manpower. 3.3 To promote entrepreneurship development for healthy industrial development. 3.4 To promote ancillary and downstream industrial parks at all major industrial hubs. 3.5 To promote specialized functional industrial area park for thrust and priority sectors. 3.6 To provide special incentive packages for promotion of thrust, priority and MSME sectors. 3.7 To fully operationalise and strengthen the industrial facilitation mechanism under Orissa Industries Facilitation ; Act 2004 and Rules 2005. 3.8 To put in place an effective grievance redressal mechanism for speedy project implementation and also for addressing post implementation issues. 4. GENERAL POLICY FRAME WORK The Industrial Policy 2007 shall pursue a multi-pronged approach for industrial promotion by providing infrastructure support, institutional support and pre and post-production incentives. While the IPR shall support industrialization in general, directed efforts shall be made to incentivise investment in thrust and priority sectors with a view to maximizing the triple objectives of value addition, employment generation and revenue augmentation. 4.1 Micro Enterprises: the focus shall be on 4.1.1 Promoting linkages with micro finance institutions. 4.1.2 Product development through design and technology support. Levels in the peripheral blood of rats were quantified using a specific rat CXCL16 ELISA. Results: CXCL16 was expressed by cells of the ciliary body and iris. In the ciliary body, CXCL16 expression significantly increased at 6 hours following LPS injection and stayed significantly elevated through the 18-hour time point n 12, P 0.05 ; . In the iris, the expression of CXCL16 paralleled its expression in the ciliary body but did not reach statistical significance. CXCR6 was also expressed on cells in the iris and ciliary body. In the ciliary body, CXCR6 showed a biphasic expression, first being significantly increased at 6 hours and 18 hours following LPS injection before returning to baseline at 24 hours and rising again 72 hours after LPS injection n 11, P 0.05 ; . In the iris, CXCR6 expression paralleled its expression in the ciliary body but only reached significance at the 72hour time point n 8, P 0.05 ; . In the peripheral blood of rats with endotoxin-induced uveitis elevated levels of CXCL16 947 69 pg ml ; were detectable at the 72-hour time point n 11, P 0.05 ; . Conclusion: This data suggests a role for CXCL16 and its receptor, CXCR6, in the pathogenesis of acute anterior uveitis. localization and occasional postaxial AER deficiency. AER anomalies were more frequent in forelimbs than hind limbs, but did not favor right versus left limb. Malformation frequency was dose dependent. Combination of chronic 2.67% ethanol diet and acute ethanol injections manifested significant and apparent additive ethanol-induced AER anomalies. However, chronic 5.3% ethanol diet combined with acute ethanol injections did not increase the frequency of AER anomalies relative to chronic diet alone. Conclusion: Chronic ethanol diet can cause both AER phenotypes seen in acute ethanol injections. However, the mechanism of AER disruption may be different from that of acute ethanol exposure because the predominant limb anomaly seen is AER mislocalization rather than AER loss. SIGNATURES The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf. TEVA PHARMACEUTICAL INDUSTRIES LIMITED By: s Dan S. Suesskind, for instance, ztimate verona. The minipill may cause irregular bleeding or amenorrhea. Danger signs: a. Abdominal pain may be due to an ovarian cyst or ectopic pregnancy. b. A delayed period after several months of regular cycles may be a sign of pregnancy. c. Repeated, very severe headaches. The minipills must be taken at about the same time every day. The margin for error is less with minipills than with combined OCs. There appear to be no significant metabolic effects and there is an immediate return to fertility upon discontinuation of the minipill. Adequate nutrition if breastfeeding. Counsel patient on use of condoms to reduce the risk of STDs HIV. If smoker or tobacco user, refer to local cessation program and or Georgia Tobacco Quit Line, 1-877-270-STOP 7867 ; . Emphasize importance of keeping immunizations current; assess client's immunization status and administer vaccines indicated according to the current Advisory Committee on Immunization Practices ACIP ; childhood or adult immunization schedule. If client declines vaccination, document refusal. See the Georgia Immunization Program Manual, Recommended Schedule and Guidelines, for current ACIP schedules and administration guidelines for each vaccine. The Georgia Immunization Manual may be accessed online at : health ate.ga publications manuals and desmopressin. In the fight against Alzheimer's disease. Alzheimer's disease is a progressive, irreversible brain disease for which there is currently no cure. It affects an estimated 4 million Americans and is the fourth leading cause of death among older adults. More than twenty thousand residents of Lee County are affected by this disease. The Alvin A. Dubin Alzheimer's Resource Center is a nonprofit organization addressing the needs of Alzheimer's persons and their families through family support, education, and advocacy. Please join us by completing and returning this form to: The Alvin A. Dubin Alzheimer's Resource Center, 10051 McGregor Blvd. Ste. 101, Fort Myers, FL 33919. Name: Address: City State Zip: Phone Optional ; MEMBERSHIP OPTIONS: Corporate Sponsor $5000 $ 500 $1000 $ 250. Title of Study: Randomized Phase 3 Study of Gemcitabine Plus Cisplatin Versus Etoposide Plus Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer NSCLC ; Investigator s ; : This multicenter study included 12 principal investigators. Study Center s ; : This study was conducted at 12 study centers in Spain. Length of Study: 1 year, 4 months July 1995 November 1996 ; Phase of Development: 3 Objectives: The primary objective of this study was to compare the response rate of gemcitabine plus cisplatin combination therapy with that of cisplatin plus etoposide combination therapy in chemonaive patients with advanced non-small cell lung cancer NSCLC ; . The secondary objectives were as follows: to compare toxicities and overall survival between the two treatment arms to evaluate changes in quality of life QoL ; over time in this patient population, as measured by psychosocial scores to estimate the cost-effectiveness of administering gemcitabine plus cisplatin versus cisplatin plus etoposide in this patient population to determine median survival. Study Design: Open-label, randomized study Number of Patients: Gemcitabine plus cisplatin: Male 64, Female 5, Total 69 Etoposide plus cisplatin: Male 61, Female 5, Total 66 Diagnosis and Main Criteria for Inclusion: Chemonaive patients, age 18 or older, were selected on the basis of a histologic or cytologic diagnosis of Stage IIIB or IV NSCLC, measurable disease, and good clinical condition Karnofsky performance status score 60, life expectancy of at least 12 weeks, and adequate bone marrow reserve ; . Test Product, Dose, and Mode of Administration: Randomization was implemented balancing patient allocation to treatment arms with respect to four potential prognostic factors: sex, performance status at baseline, disease stage at baseline, and investigational site. The 21-day schedules described below defined a cycle of treatment. Multiple cycles were administered. Gemcitabine plus cisplatin treatment arm: Gemcitabine was administered intravenously as a continuous infusion over 30 minutes once each week for 2 weeks at a dose of 1250 mg m2, followed by 1 week of rest. Cisplatin was administered intravenously before the gemcitabine infusion on Day 1, at a dose of 100 mg m2. Etoposide plus cisplatin treatment arm: Etoposide was administered intravenously at a dose of 100 mg m2 on Days 1, 2, and 3 of each 21-day cycle. Cisplatin was administered before the etoposide infusion on Day 1, at a dose of 100 mg m2 of each 21-day cycle. Quantity sufficient to last until the patient's visit to their physician or until the prescription can be obtained, has been rejected. However, we received approval to proceed with emergency contraception only. As a result, Council passed another corresponding bylaw amendment for submission to the Minister for approval. In the meantime, we are working with the College of Pharmacy and Nutrition to prepare the education program for members and further details will follow. Council agreed to lobby Saskatchewan Health, supporting the concept of prescriptive authority for pharmacists and allowing pharmacists to dispense prescription drugs without a prescription when the patient is stabilized on chronic therapy. Council approved the NAPRA model internet pharmacy standards modified in consultation with the College of Physicians and Surgeons to incorporate a statement on the validity of prescriptions. Amongst other things this means that the pharmacist should not dispense the prescription when there is reason to believe that an appropriate physician-patient relationship does not exist. The complete standards will be circulated to all pharmacies. Council approved a NAPRA model standard permitting temporary pharmacy closures for up to 14 consecutive days per year. The complete standards will be circulated to all pharmacies. Council approved a report confirming the transfer of membership in the Canadian Pharmacists Benefits Association and responsibility for insurance programs to the Representative Board of Saskatchewan Pharmacists. Primary Health Care Teams Council reviewed the results of the last faxback survey of members. Although the results are disappointing, Council agreed to continue incorporating this feedback as we address this issue. Linkage with the Public Do you meet with groups, provide educational seminars, conduct special programs in your pharmacy? If you are involved in any special way in linking with the public, Council would like to hear from you. In particular we would like to receive a brief description of the event, and your comments on how you believe the public benefited. Send your reports to the SPhA office and we will circulate them to Council. Has shown evidence of influenza infection in 57% of unvaccinated elderly patients in hospital long-term care [8, 21]. It is difficult to compare these figures directly with community studies. Different studies have used different methods of virological surveillance. Testing of paired serum samples may be particularly misleading, as immunocompromised subjects in hospital care may not mount a detectable antibody response, and those who die of influenza cannot contribute a post-infection serum sample. It is likely that virological surveillance underestimates the proportion of patients who are infected with influenza. Many elderly long-term patients have chronic illness, malnourishment and associated disability. In general, there is a gradient of disability, with the most disabled subjects in hospital geriatric medical care, followed by private nursing care, while those in residential care tend to be the least disabled [22]. Elderly subjects in private nursing homes in North America and continental Europe tend to be less disabled than private nursing home residents in the UK. Subjects who are more disabled would carry the greatest risks of death should they contract influenza. In long-term care, it is likely that staffpatient crossinfection is the most common route of infection, in particular from nurses, who have prolonged close contact with patients. Relatives and other visitors may also bring influenza into wards. Patientpatient cross-infection then perpetuates the process. A substantial proportion of health care workers are infected by influenza over the winter period. One study showed serological evidence of infection in ~20% of unvaccinated health care workers each winter W. F. Carman et al., unpublished observations ; [2]. A study of unvaccinated doctors found 13% with serological evidence over the winter period [23]. Approximately 50% have minor symptoms or are asymptomatic [2], and are likely to continue to work while infectious, acting as a source of virus for their patients and colleagues. Pharmaceutical companies are forced to work in a highly regulated environment in which legislative changes keep coming up. This workshop is aimed at people that work with or in pharmaceutical companies and or regulatory bodies and therefore have to be prepared for this constantly changing environment. Lovells brings solutions from their extensive industry experience on how a good preparation can result in better patent and data protection etc. Registration for the workshop is at 09.00, and the workshop will run from 09.30-16.30, lunch and breaks included, for example, stimmate nasal spray. Governing factor in determining if such a project should go forward. The balance of this feasibility study is intended to combine feasibility, planning, and predevelopment tasks, the objectives of which are to: a ; identify specific site preparation work that could be completed as soon as possible; b ; complete analyses required to finalize the location of proposed wind turbines; c ; estimate the project economics; and d ; identify technical data that can be used in preparing applications or notices for anticipated permits and approvals. Accordingly, the scope of this study and this report includes the following: 1. Perform a high-level site screening analysis to identify and evaluate factors that would make it infeasible, inappropriate, or overly difficult to develop the project and potential wind turbine configuration options, analyze the aspects of wind energy development, and assess how they impact a potential wind turbine installation at the watershed site. 2. Prepare photo-simulations depicting one wind turbine from up to four vantage points. 3. Identify and evaluate required permits and approvals, including federal, state, local, and utility interconnection requirements, including: identify and list required permits and approvals; identify additional research that must be completed prior to filing for permits and approvals; and estimate the required timeframe for securing permits and approvals. 4. Evaluate technical issues related to development of the project, including: site characteristics; electrical infrastructure; neighborhood impacts; environmental impacts; recommendations for the wind turbine location; identify technical issues associated with the project; and develop detailed, project-specific information required for permitting and approvals processes. 5. Prepare a project site plan with preliminary layout of wind turbine, components and interconnection point. 6. Review and evaluate wind data collected on site by other parties, including correlation with appropriate long-term wind data sources, to the extent feasible, including: refine estimates of the wind resource at the project site; and develop a wind resource profile for use in estimating annual electricity production and the allocation of generated electricity between on-site loads and exports to the grid. 7. Characterize on-site electric loads, including diurnal and seasonal variability, and understand the potential for use of wind-generated electricity on site. 8. Estimate turbine annual energy production and the allocation of generated electricity between on-site loads and exports to the grid, including: estimate predicted life-cycle productivity of the wind turbine; and estimate the potential value of wind-generated electricity. 9. Prepare a preliminary economic analysis, including: identify assumed capital, reserve, operating, and maintenance costs; and estimate life-cycle energy production costs. Throughout this report, data and results are provided in Systme International "SI" ; units metric units ; to be consistent with the raw data available and to be consistent with wind industry standard practice; accordingly, with a few exceptions data are not represented in traditional British American-based English units. 1st dam LAMP OF PHOEBUS USA ; : ran twice at 3; dam of 6 previous foals; 4 runners; 1 winner: Daphodil IRE ; 00 f. by Mujadil USA : winner at 4, 2004 in Sweden and placed 3 times. She also has a yearling colt by Fruits of Love USA ; . 2nd dam SIALA FR ; : placed 4 times at 3 in France and 39, 400 fr.; dam of 6 winners inc.: ACCOMMODATING USA ; f. by Akarad FR : 2 wins in France inc. Prix Ronde de Nuit, L., placed 2nd Prix Vanteaux, Gr.3 and 3rd Prix Saint-Alary, Gr.1; grandam of GO ROCKIN' ROBIN USA ; won Peter Pan S., Gr.2, 3rd Damon Runyon S., L., New York Derby, L., Whirlaway S., L. ; . Basic USA ; : 6 wins in U.S.A. and $159, 626. Meenshar FR ; : 4 wins in Belgium and in France; dam of a winner. Clevermen USA ; : 2 wins in U.S.A. Siamese USA ; : winner in 2003 in France and placed 13 times. 3rd dam STOYANA FR ; by Abdos ; : 2 wins at 3 in France and 51, 800 fr. and placed twice; Own sister to ABGAL FR dam of 6 winners inc.: SADJIYD FR ; : 4 wins at 2 and 3 in France and 782, 000 fr. and $152, 300 inc. Prix Noailles, Gr.2 and Prix Hocquart, Gr.2, placed twice viz. 2nd Rothman's International S., Gr.1 and Prix du Prince d'Orange, Gr.3; sire. Sidama FR ; : 4 wins at 3 in France and placed 4 times; dam of 9 winners inc.: SINNTARA IRE ; : 4 wins at 3 and 25, 757 inc. Giolla Mear Race, L., placed twice; dam of SINNDAR IRE ; , Champion 3yr old in Europe in 2000, 7 wins at 2 and 3 at home and in France and 1, 750, 841 inc. Vodafone Derby S., Gr.1, Irish Derby, Gr.1, National S., Gr.1, P. de l'Arc de Triomphe, Gr.1, Prix Niel, Gr.2 and Derrinstown Stud Derby Trial S., Gr.3; sire ; . MISTINGUETT IRE ; : 6 wins, 119, 341 viz. winner at 2 and placed 3 times; also 5 wins over hurdles inc. Cleeve Hurdle, Gr.1, Bellcharm Mitsubishi Champion Trial Hurdle, Gr.2 and Knights Royal Hurdle, L., placed 12 times inc. 2nd Triumph Hurdle, Gr.1; dam of MISTERNANDO GB ; 10 wins at 3, 2003 and 109, 931 inc. Willie Park Trophy S., L., placed 6 times inc. 3rd Lady O Goodwood Cup, Gr.2 and Addleshaw Goddard Esher S., L. ; . Sabaniya FR ; : winner of a N.H. Flat Race and placed twice; dam of a winner: Chaguaramas IRE ; : winner at 2, placed 2nd Stardom S., L. 4th dam BIELKA FR ; : ran on the flat in France; dam of 3 winners inc.: ABGAL FR ; : 5 wins inc. winner in France viz. Prix La Force. Perinthe: dam of 4 winners inc.: THE DAAN FR ; : 2 wins in Italy inc. Premio Mediterraneo, L. Tudorville FR ; : 2 wins in France placed 2nd Prix Belle de Nuit, L. Stabled in Barn J Box 3. These include not only crude herb preparations but also compounds composed of or derived from herbs and other medicinal plants. Pramide ; . Of 100 cancer patients treated with oral cannabinoids during chemotherapy, 16 will not be nauseated number needed to treat 6.4 ; and 13 will not vomit 8 ; who would have done so had they all received a conventional antiemetic. Compared with placebo, cannabinoids were obviously better, although a placebo may not be an adequate comparator in patients having chemotherapy. We could not establish a dose-response relation, mainly because there were insufficient quality data from the original trials. In some trials, dose was adjusted during the trial.34 The relation between plasma concentration of a cannabinoid and its antiemetic efficacy is unclear. In one trial, antiemetic efficacy was related to the plasma concentration of dronabinol.35 Another trial found no correlation between dronabinol serum levels and efficacy or adverse reactions.41 Defining an intervention's usefulness includes estimates of the likelihood for harm. The physical and neuropsychiatric adverse effects of long term use of cannabis are well established, based mainly on observations from long term marijuana smokers.62 Our systematic review shows clearly that cannabinoids are toxic for many patients even when taken orally and acutely for 24 hours ; . Some adverse effects occurred almost exclusively with cannabinoid exposure. For instance, 5% of patients had paranoia, 6% had hallucinations, and almost 13% had dysphoria or depression table 3 ; . The number of patients withdrawing from the studies due to intolerable side effects is the most reliable parameter of the severity of cannabinoid related toxicity. One in eleven patients treated with cannabinoids will stop treatment who would not have stopped treatment had they taken a placebo or another antiemetic. This is an important new message for doctors, policy makers, and patients. These results should make us think hard about the ethics of clinical trials of cannabinoids when safe and effective alternatives are known to exist and when efficacy of cannabinoids is known to be marginal. The trials analysed here are likely to be the largest subgroup on the medical use of cannabinoids and therefore the single most important source of information on their potential for harm. Effect of bias This meta-analysis is open to some biases, and they all have the potential to overestimate the efficacy and to underestimate the harm of cannabinoids. The trials we included were of acceptable quality according to the Oxford quality scale, with 25 of 30 trials scoring 3 or 4. 70% of trials an adequate method of blinding was described. Most crossover trials used a double dummy design. Cannabinoids were given as tablets or intramuscular injection, so any psychological effect of smoking a joint was not a factor. However, cannabinoids showed specific adverse effects that control treatments did not, and their incidence was high. In one trial of oral nabilone, many patients identified which drug they received because of the adverse effects experienced.59 In a series of 100 blinded dronabinol and placebo treatments, nurses correctly identified the active treatment in 85% and patients in 95%; seven of the 10 errors were made by patients on the first drug trial of the study.63 We must therefore assume that most of these trials had some degree of observer bias. 250 East Fifth Street Cincinnati, Ohio 45202 To the Board of Directors and Shareholders of The Procter & Gamble Company: We have audited the accompanying consolidated balance sheets of The Procter & Gamble Company and subsidiaries as of June 30, 2001 and 2000 and the related consolidated statements of earnings, shareholders' equity and cash flows for each of the three years in the period ended June 30, 2001. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company at June 30, 2001 and 2000 and the results of its operations and cash flows for each of the three years in the period ended June 30, 2001, in conformity with accounting principles generally accepted in the United States of America.
|
